Results 111 to 120 of about 18,145 (196)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis

Clinical Ophthalmology, 2013
Masahiro Miura,1,2 Takuya Iwasaki,1,2 Hiroshi Goto2 1Department of Ophthalmology, Tokyo Medical University, Ibaraki Medical Center, Ami, Ibaraki, Japan; 2Department of Ophthalmology, Tokyo Medical University, Nishi-Shinjuku, Tokyo, Japan Purpose: To ...
Miura M, Iwasaki T, Goto H
doaj  

Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study [PDF]

Debdulal Chakraborty,1 Subhendu Boral,1 Tushar Kanti Sinha,1 Arnab Das,1 Angshuman Mukherjee,1 Saptorshi Majumdar,1 Ranabir Bhattacharya,2 Ritobroto Maitra3 1Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India ...
Majumdar S, Chakraborty D, Bhattacharya R, Boral S, Das A, Mukherjee A, Maitra R, Sinha TK   +7 more
core  

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation

, 2016
Luis Arias,1–3 Francisco Gómez-Ulla,2–4 José M Ruiz-Moreno2,3,51Ophthalmology Department, Bellvitge University Hospital, C/Feixa Llarga, L’Hospitalet de Llobregat, Barcelona, 2Spanish Vitreoretinal Society (SERV), C/Xos ...
Arias L, Ruiz-Moreno JM, Gómez-Ulla F
core  

Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration

, 2013
Georgios D Panos,1 Zisis Gatzioufas,1 Ioannis K Petropoulos,1 Doukas Dardabounis,2 Gabriele Thumann,1 Farhad Hafezi11Department of Ophthalmology, Geneva University Hospitals and Faculty of Medicine of the University of Geneva, Switzerland; 2Department of
Gatzioufas Z, Dardabounis D, Hafezi F, Petropoulos IK, Panos GD, Thumann G   +5 more
core  

Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial

, 2018
Andrea Russo,1 Nicolò Scaroni,1 Elena Gambicorti,1 Raffaele Turano,1 Francesco Morescalchi,1 Ciro Costagliola,2 Francesco Semeraro1 1Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, 2Eye Clinic ...
Morescalchi F, Semeraro F, Gambicorti E, Russo A, Turano R, Scaroni N, Costagliola C   +6 more
core  

The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing

, 2013
John B Christoforidis,1 Jillian Wang,2 Angela Jiang,2 James Willard,5 Cedric Pratt,2 Mahmoud Abdel-Rasoul,3 Sashwati Roy,4 Heather Powell51Department of Ophthalmology and Vision Science, College of Medicine, The University of Arizona, Tucson, AZ, USA ...
Christoforidis JB, Jiang A, Roy S, Pratt C, Abdel-Rasoul M, Wang J, Willard J, Powell HM   +7 more
core  

Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia

, 2013
Alexandros Rouvas,1 Panagiotis Malamos,2 Maria Douvali,1 Amalia Ntouraki,1 Nikos N Markomichelakis1 12nd Department of Ophthalmology, Medical School of Athens University, Athens, Greece; 2Department of Ophthalmology, NHS, “G Gennimatas&rdquo ...
Douvali M, Ntouraki A, Rouvas A, Malamos P, Markomichelakis NN   +4 more
core  

Real-World Analysis of Switching Between Ranibizumab Biosimilars: Safety and Results - a Multicenter Retrospective Observational Study. [PDF]

Clin Ophthalmol
Chakraborty D, Sinha TK, Biswas RK, Maiti A, Barman MJ, Bhattacharya R, Boral S, Das A.   +7 more
europepmc   +1 more source

Ranibizumab in the treatment of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome

, 2010
Luis Arias1,2, Jordi Monés21Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona; 2Institut de la Màcula i de la Retina, Centro Médico Teknon, BarcelonaPurpose: To describe a case of ...
Jordi Monés, Luis Arias
core  

Comparative Histopathological Effects of Intra-Articular Bevacizumab, Ranibizumab, and Aflibercept in Experimental Osteoarthritis. [PDF]

J Clin Med
Dalaslan RE, Arıcan M, Karaduman ZO, Yücel MO, Sağlam S, Demir F, Çelik M.   +6 more
europepmc   +1 more source